Erythropoietin Involves the Phosphatidylinositol 3-kinase Pathway, 14-3-3 Protein and Foxo3a Nuclear Trafficking to Preserve Endothelial Cell Integrity.
From: Division of Cellular and Molecular Cerebral Ischemia, Center for Molecular Medicine and Genetics, Institute of Environmental Health Sciences, Wayne State University School of Medicine, Detroit, MI 48201, USA.
British journal of pharmacology
- Publish Date: Apr 2007
- ISSN: 0007-1188
- Volume: 150
- Issue: 7
- Pages: 839-50
- Medium: Print
- Language: English
- Citation (JAMA): Chong Z Z, Maiese K, et al. Erythropoietin Involves the Phosphatidylinositol 3-kinase Pathway, 14-3-3 Protein and Foxo3a Nuclear Trafficking to Preserve Endothelial Cell Integrity.. Br. J. Pharmacol. Apr 2007;150:839-50
Abstract
BACKGROUND AND PURPOSE: Clinical indications for erythropoietin (EPO) in the vascular system reach far beyond the treatment of anemia, but the development of EPO as a non-toxic agent rests heavily upon the cellular pathways controlled by EPO that require elucidation. EXPERIMENTAL APPROACH: We modulated gene activity and examined cellular trafficking of critical pathways during oxidative stress that may work in concert with EPO to protect primary cerebral endothelial cells (ECs) during oxidative stress, namely protein kinase B (Akt1), 14-3-3 protein, the Forkhead transcription factor FOXO3a. KEY RESULTS: Here, we show that preservation of ECs by EPO during oxygen-glucose deprivation (OGD) required the initial activation of the phosphatidylinositol 3-kinase (PI-3K) pathway through Akt1, since specific pharmacological blockade of Akt1 activity or gene silencing of Akt1 prevented EC protection by EPO. EPO subsequently involved a series of anti-apoptotic pathways to activate STAT3, STAT5, and ERK 1/2. Furthermore, EPO maintained the inhibitory phosphorylation and integrity of the ‘pro-apoptotic’ transcription factor FOXO3a, promoted the binding of FOXO3a to 14-3-3 protein and regulated the intracellular trafficking of FOXO3a. Additionally, gene silencing of FOXO3a during OGD significantly increased EC survival, but did not synergistically improve cytoprotection by EPO, illustrating that EPO relied upon the blockade of the FOXO3a pathway. CONCLUSIONS AND IMPLICATIONS: Our work defines a novel cytoprotective pathway in ECs that involves PI-3 K, STAT3, STAT5, ERK 1/2, 14-3-3 protein and FOXO3a, which can be targeted for the development of EPO as a clinically effective and safe agent in the vascular system.
Mesh Headings (Keywords): 1-Phosphatidylinositol 3-Kinase, 14-3-3 Proteins, Animals, Cell Hypoxia, Cell Survival, Cells, Cultured, Endothelial Cells, Erythropoietin, Forkhead Transcription Factors, Glucose, Male, Protein Transport, Proto-Oncogene Proteins c-akt, Rats, Rats, Sprague-Dawley, STAT3 Transcription Factor, STAT5 Transcription Factor
Check for Full Text / PubMed Unique Identifier (PMID): 17339844
This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.
Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.
The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.